These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36767947)

  • 21. sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction.
    Plawecki M; Morena M; Kuster N; Chenine L; Leray-Moragues H; Jover B; Fesler P; Lotierzo M; Dupuy AM; Klouche K; Cristol JP
    Mediators Inflamm; 2018; 2018():3952526. PubMed ID: 30402040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble ST2 in end-stage heart failure, before and after support with a left ventricular assist device.
    Tseng CCS; Huibers MMH; Gaykema LH; Siera-de Koning E; Ramjankhan FZ; Maisel AS; de Jonge N
    Eur J Clin Invest; 2018 Mar; 48(3):. PubMed ID: 29325227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Soluble ST2 Levels and Beta-Blockers Dosage on Cardiovascular Events of Patients with Unselected ST-Segment Elevation Myocardial Infarction.
    Huang WP; Zheng X; He L; Su X; Liu CW; Wu MX
    Chin Med J (Engl); 2018 Jun; 131(11):1282-1288. PubMed ID: 29786039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased ratio of sST2/LVMI predicted cardiovascular mortality and heart failure rehospitalization in heart failure with reduced ejection fraction patients: a prospective cohort study.
    Li F; Xu M; Fu M; Cui X; Lian Z; Xin H; Zhou J; Ge J
    BMC Cardiovasc Disord; 2021 Aug; 21(1):396. PubMed ID: 34404341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble ST2 in heart failure.
    Dieplinger B; Mueller T
    Clin Chim Acta; 2015 Mar; 443():57-70. PubMed ID: 25269091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction.
    Shah KB; Kop WJ; Christenson RH; Diercks DB; Henderson S; Hanson K; Li SY; deFilippi CR
    Clin Chem; 2011 Jun; 57(6):874-82. PubMed ID: 21515743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble ST2 and IL-33: Potential markers of endometriosis in the Tunisian population.
    Mbarik M; Kaabachi W; Henidi B; Sassi FH; Hamzaoui K
    Immunol Lett; 2015 Jul; 166(1):1-5. PubMed ID: 25977120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction.
    Zhang K; Zhang XC; Mi YH; Liu J
    Chin Med J (Engl); 2013; 126(19):3628-31. PubMed ID: 24112154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
    Pusceddu I; Dieplinger B; Mueller T
    Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of serum sST2 and sCD40L values in patients with microvascular angina.
    Aslan G; Polat V; Bozcali E; Opan S; Çetin N; Ural D
    Microvasc Res; 2019 Mar; 122():85-93. PubMed ID: 30502363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A role for soluble ST2 in vascular remodeling associated with obesity in rats.
    Martínez-Martínez E; Miana M; Jurado-López R; Rousseau E; Rossignol P; Zannad F; Cachofeiro V; López-Andrés N
    PLoS One; 2013; 8(11):e79176. PubMed ID: 24265755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble ST2 and myocardial fibrosis in 3T cardiac magnetic resonance.
    Quick S; Waessnig NK; Kandler N; Poitz DM; Schoen S; Ibrahim K; Strasser RH; Speiser U
    Scand Cardiovasc J; 2015; 49(6):361-6. PubMed ID: 26287645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection.
    Mehraj V; Jenabian MA; Ponte R; Lebouché B; Costiniuk C; Thomas R; Baril JG; LeBlanc R; Cox J; Tremblay C; Routy JP;
    AIDS; 2016 Jun; 30(10):1617-27. PubMed ID: 27045377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma soluble ST2 levels correlate with disease severity and predict clinical worsening in patients with pulmonary arterial hypertension.
    Zheng YG; Yang T; He JG; Chen G; Liu ZH; Xiong CM; Gu Q; Ni XH; Zhao ZH
    Clin Cardiol; 2014 Jun; 37(6):365-70. PubMed ID: 25068163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble Suppression of Tumorigenicity 2 and Echocardiography in Sepsis.
    Yang HS; Hur M; Kim H; Magrini L; Marino R; Di Somma S;
    Ann Lab Med; 2016 Nov; 36(6):590-4. PubMed ID: 27578513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased soluble ST2 and IL‑4 serum levels are associated with disease severity in patients with membranous nephropathy.
    Zhang Z; Liu X; Wang H; Qu Z; Crew R; Zhang N; Jiang Y
    Mol Med Rep; 2018 Feb; 17(2):2778-2786. PubMed ID: 29207152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-33 and Soluble ST2 as Potential Biomarkers of Cancer in Opium Users: A Nested Case-Control Study.
    Firouzabadi N; Javdani K; Dehshahri A
    Iran J Med Sci; 2022 Nov; 47(6):541-548. PubMed ID: 36380972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction.
    Tymińska A; Kapłon-Cieślicka A; Ozierański K; Budnik M; Wancerz A; Sypień P; Peller M; Balsam P; Opolski G; Filipiak KJ
    Dis Markers; 2019; 2019():9529053. PubMed ID: 31687050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble ST2, a modulator of the inflammatory response, in preterm and term labor.
    Stampalija T; Chaiworapongsa T; Romero R; Tarca AL; Bhatti G; Chiang PJ; Than NG; Ferrazzi E; Hassan SS; Yeo L
    J Matern Fetal Neonatal Med; 2014 Jan; 27(2):111-21. PubMed ID: 23688338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum soluble ST2 is a promising prognostic biomarker in HBV-related acute-on-chronic liver failure.
    Jiang SW; Wang P; Xiang XG; Mo RD; Lin LY; Bao SS; Lu J; Xie Q
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):181-188. PubMed ID: 28381383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.